Incyte (INCY) Enterprise Value (2010 - 2026)
Incyte's (INCY) quarterly Enterprise Value came in at $18.2 billion in Q2 2026, up 68.98% on a YoY basis from $10.8 billion in Q2 2025, and up 23.26% quarter-over-quarter from $14.8 billion in Q1 2026.
Analysis
Incyte (INCY) Enterprise Value (2010 - 2026) Analysis & Trends
Incyte (INCY) has reported Enterprise Value for 17 consecutive years, with $18.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Enterprise Value rose 68.98% year-over-year to $18.2 billion; the trailing twelve-month figure through Jun 2026 stood at $18.2 billion (up 68.98% YoY), and the FY2025 full-year result was $16.0 billion, up 43.02% from the prior year.
- Enterprise Value improved to $18.2 billion in Q2 2026 per INCY's latest filing, from $14.8 billion in the prior quarter.
- Across five years, Enterprise Value topped out at $18.2 billion in Q2 2026 and bottomed at $8.9 billion in Q1 2024.
- Historically, Enterprise Value has averaged $12.4 billion across 5 years, with a median of $11.5 billion in 2022.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value plunged 31.27% in 2024, then surged 68.98% in 2026.
- Over 5 years, Enterprise Value stood at $14.7 billion in 2022, then retreated by 28.84% to $10.4 billion in 2023, then rose by 7.44% to $11.2 billion in 2024, then soared by 43.02% to $16.0 billion in 2025, then rose by 13.89% to $18.2 billion in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered $18.2 billion, $14.8 billion, and $16.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.25 Bn |
| Mar 31, 2026 | 14.80 Bn |
| Dec 31, 2025 | 16.02 Bn |
| Sep 30, 2025 | 13.70 Bn |
| Jun 30, 2025 | 10.80 Bn |
| Mar 31, 2025 | 9.32 Bn |
| Dec 31, 2024 | 11.20 Bn |
| Sep 30, 2024 | 10.97 Bn |
| Jun 30, 2024 | 10.16 Bn |
| Mar 31, 2024 | 8.94 Bn |
| Dec 31, 2023 | 10.43 Bn |
| Sep 30, 2023 | 9.43 Bn |
| Jun 30, 2023 | 10.48 Bn |
| Mar 31, 2023 | 13.01 Bn |
| Dec 31, 2022 | 14.65 Bn |
| Sep 30, 2022 | 11.85 Bn |
| Jun 30, 2022 | 14.13 Bn |
| Mar 31, 2022 | 15.04 Bn |
| Dec 31, 2021 | 13.88 Bn |
| Sep 30, 2021 | 12.91 Bn |